optimapharm.eu Open in urlscan Pro
35.214.99.200  Public Scan

Form analysis
1 forms found in the DOM

GET https://optimapharm.eu/

<form role="search" action="https://optimapharm.eu/" method="GET"> <input type="text" name="s" id="s" value="" aria-label="Search" placeholder="Search"> <span>Hit enter to search or ESC to close</span></form>

Text Content

Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
 * What we do
   * Areas of expertise
   * Scope of activity
   * Who we work with
     * Pharmaceutical companies
     * Biotechnology businesses
     * Medical Device companies
 * Where we are
 * Collaborating with us
 * Who we are
   * Our mission & values
   * Our team
   * Corporate Responsibility
   * Ethics and Compliance
   * Our history
 * Join us
 * News & events
 * REQUEST PROPOSAL




WE DELIVER ON YOUR PROMISES


HELPING YOU EXPEDITE THE DEVELOPMENT OF NEW MEDICINES, THERAPIES AND TREATMENTS
THAT ADVANCE HUMAN HEALTH ACROSS THE GLOBE.


WHETHER A PHARMACEUTICAL, BIOTECH OR MEDICAL DEVICE COMPANY, WE ARE YOUR IDEAL
PAN-EUROPEAN, FULL-SERVICE CRO.
OUR IN-DEPTH EXPERTISE AND LONG LASTING EXPERIENCE COMBINED WITH A FLEXIBLE, AND
COLLABORATIVE APPROACH ALLOW US TO TAILOR OUR RESPONSES TO EACH INDIVIDUAL
STUDY.


OUR CLINICAL DEVELOPMENT CAPABILITIES SPAN THROUGH TRIAL PHASES I-IV, ACROSS A
BROAD RANGE OF THERAPEUTIC AREAS INCLUDING MEDICAL DEVICES.
WE HAVE AN EXCELLENT TRACK RECORD FOR SUPPORTING A RANGE OF STAKEHOLDERS IN THE
PHARMACEUTICAL INDUSTRY INCLUDING SPONSORS AND RESEARCH INSTITUTIONS AT EACH
CLINICAL DEVELOPMENT PHASE.




1500



COMPLETED
PROJECTS


95

%


REPEAT
BUSINESS


87

%


POSITIVE
RECOMMENDATION


8



SITE INSPECTIONS
FROM EMA/FDA COMPLETED


TAILOR-MADE SOLUTIONS

Your effective and rigorously compliant project strategy will be tailor-made to
the specific requirements of your clinical trial. Our flexibility in project
design and implementation, based on our in hours expertise and experience is
backed up by delivering full-service with deep local expertise across Europe.

Review services »




YOUR REGULATORY AND OPERATIONAL LOCAL EXPERT

You gain access to a population of more than 500 million people throughout our
24 offices in strategic locations in Europe. Currently, we’re running more than
300 active trials in 36 different countries.

Explore locations »


DELIVERY FOCUSED

A proud track record of accelerated start-up timelines, over-achievement of
recruitment targets, early completions and cost competitive budgetary adherence
demonstrates that we are extremely focused at running efficient and effective
clinical trials.

Discover more »




13

Completed 111% target recruitment five months early for a Phase III oncology
trial with 30 sites.


200%

Achieved 200% recruitment in the planned timelines in an asthma trial, securing
767 participating patients at 13 sites.


+649

Rescued a Phase III ACS study, recruiting 649 patients at 57 sites in 5
countries. Completed 4 months early.


1ST

First EU patient enrolled for a global rare disease clinical trial.


139%

Achieved 139% recruitment in a phase III CABP study, 4 sites in Serbia enrolled
17.6% of all patients. The study altogether involved 164 sites in 20 countries.
Two FDA inspections with no findings.


-6

Completed a DM Type 1 pediatric trial 6 months early and achieved 160% of
patient recruitment target.

 1. 
 2. 




SHARED GOALS

You need a CRO partner who is as invested in the success of each bespoke
clinical trial as you are. We collaborate closely, constantly making sure that
we are aligned with your study expectations and key study milestones.
Essentially, we become an extended arm to your team with the same shared goals.

PHARMACEUTICAL COMPANIES

DELIVERY-FOCUSED BESPOKE SOLUTIONS FOR ALL PHASES OF DRUG DEVELOPMENT.

More »

BIOTECHNOLOGY ENTERPRISES

DEDICATED SERVICE AND EXPERTISE THAT DELIVERS HIGH-QUALITY, COST-EFFECTIVE
RESULTS.

More »

MEDICAL DEVICE COMPANIES

SMART SOLUTIONS BUILT ON A COMBINATION OF REGULATORY EXPERTISE AND DEEP
UNDERSTANDING OF PROJECT SPECIFICITIES.

More »


NEWS

October 28, 2022 in News


OPTIMAPHARM FURTHER EXPANDS IN THE US TO ENHANCE CUSTOMER COLLABORATION

Optimapharm Further Expands in the US to Enhance Customer Collaboration We
Deliver on Your Promises In line with its strategic growth plans, Optimapharm
has opened a new office in Boston, Massachusetts this September. The role of
this office will be…
Read More
October 3, 2022 in News


OPTIMAPHARM ANNOUNCES EUCROF WEBINAR PRESENTATION

Person-Centric Clinical Trials - Webinar Optimapharm announces Ana Stojković as
a speaker at the EUCROF webinar - Person-Centric Clinical Trials.  Optimapharm
is delighted to share that our VP of Clinical Operations - Ana Stojković, will
be one of the speakers…
Read More
September 28, 2022 in News


OPTIMAPHARM CONFERENCE ATTENDANCE IN Q3 & Q4 OF 2022

Optimapharm Announces Conferences Attendance in Q4 of 2022 Optimapharm d.o.o.
(“Optimapharm”), a leading European, mid-sized, full-service Clinical Research
Organization (CRO), is pleased to announce its attendance at conferences in Q4
of 2022. BIO EUROPE 2022 BIO-Europe has a long track…
Read More
June 27, 2022 in News


OPTIMAPHARM ANNOUNCES ACQUISITION OF QUALITIS SA

Optimapharm Announces Acquisition of Qualitis SA We Deliver on Your Promises
Optimapharm d.o.o. (“Optimapharm”), a leading European, mid-sized, full-service
Clinical Research Organization (CRO), is pleased to announce the acquisition of
Qualitis SA (“Qualitis”). This acquisition will complement Optimapharm’s
geographic coverage…
Read More

View more articles »

> “
> 
> I would like to thank you all for the tremendous work done to reach this
> important milestone for the study in a very challenging and complex global
> environment. It is the first of many others that we will have to achieve
> together. Let's keep it up!
> 
> Clinical Project Leader, Big Pharma Company

> “
> 
> We are very grateful for your hard work and dedication over the past few
> years. We are delighted to be part of this partnership and look forward to
> start treating patients in this new therapeutic area soon. We could not have
> done this without your contribution. We are very excited about the path ahead
> and can hardly wait to start this study.
> 
> Chief Executive Officer, Biotech Company

> “
> 
> Corporate team and I would like to sincerely thank all the team members, both
> global and local, as well as the site staff, who have worked extremely hard to
> reach this lock! This has been achieved under difficult circumstances, being
> significantly earlier than planned for this discontinued study and in the
> middle of the COVID-19 pandemic with lockdowns or curfews in place in many of
> the countries. A huge thank you to all for your team spirit and commitment to
> reach this goal!
> 
> Clinical Project Lead, Big Pharma Company

> “
> 
> Very pleased. Looking forward to getting the country up and running soon.
> 
> VP Global Clinical Operations, Medical Device Company

 * 
 * 
 * 
 * 

Let's talk about your study needs 

REQUEST PROPOSAL



PRIVACY POLICY »



ONLINE PRIVACY POLICY »



GDPR INFORMATION »



COOKIE POLICY »



CORPORATE INFORMATION »




HEAD OFFICE
ALMERIA BUSINESS TOWER
ULICA GRADA VUKOVARA 284
10000 ZAGREB, CROATIA



T: +385-1-560 3600



© 2021 OPTIMAPHARM.
ALL RIGHTS RESERVED




INTERESTED IN A CAREER WITH US?

VIEW CURRENT OPPORTUNITIES »



 

CONNECT WITH US »






Close Menu
 * What we do
   * Back
   * Areas of expertise
   * Scope of activity
   * Who we work with
     * Back
     * Pharmaceutical companies
     * Biotechnology businesses
     * Medical Device companies
 * Where we are
 * Collaborating with us
 * Who we are
   * Back
   * Our mission & values
   * Our team
   * Corporate Responsibility
   * Ethics and Compliance
   * Our history
 * Join us
 * News & events
 * REQUEST PROPOSAL



Optimapharm
Optimapharm.eu does not use tracking cookies or other tracking technology. Only
necessary cookies are used in order to properly display the website and this
message. You can find out more about the way we process and protect Personal
Data in our Privacy Policy and Cookie Policy.
I Understand
Manage consent
Close

PRIVACY OVERVIEW

Optimapharm.eu does not use cookies or tracking. You can find out about the way
we process Personal Data in our Privacy Policy
Necessary
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly.
These cookies ensure basic functionalities and security features of the website,
anonymously.

CookieDurationDescriptioncookielawinfo-checkbox-functional11 monthsThe cookie is
set by GDPR cookie consent to record the user consent for the cookies in the
category "Functional".cookielawinfo-checkbox-necessary11 monthsThis cookie is
set by GDPR Cookie Consent plugin. The cookies is used to store the user consent
for the cookies in the category "Necessary".viewed_cookie_policy11 monthsThe
cookie is set by the GDPR Cookie Consent plugin and is used to store whether or
not user has consented to the use of cookies. It does not store any personal
data.

Functional
Functional
Functional cookies help to perform certain functionalities like sharing the
content of the website on social media platforms, collect feedbacks, and other
third-party features.
Performance
Performance
Performance cookies are used to understand and analyze the key performance
indexes of the website which helps in delivering a better user experience for
the visitors.
Analytics
Analytics
Analytical cookies are used to understand how visitors interact with the
website. These cookies help provide information on metrics the number of
visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and
marketing campaigns. These cookies track visitors across websites and collect
information to provide customized ads.
Others
Others
Other uncategorized cookies are those that are being analyzed and have not been
classified into a category as yet.
SAVE & ACCEPT
Powered by